Illumina Stock Price, News & Analysis (NASDAQ:ILMN)

$253.91 +2.30 (+0.91 %)
(As of 03/19/2018 05:06 AM ET)
Previous Close$251.61
Today's Range$252.24 - $256.64
52-Week Range$158.64 - $256.64
Volume1.09 million shs
Average Volume932,577 shs
Market Capitalization$37.32 billion
P/E Ratio51.19
Dividend YieldN/A

About Illumina (NASDAQ:ILMN)

Illumina logoIllumina, Inc. provides sequencing and array-based solutions for genetic analysis. The company operates in two segments, Core Illumina and Consolidated VIEs. It offers sequencing by synthesis technology that provides researchers with various applications and the ability to sequence mammalian genomes; and arrays for a range of deoxyribonucleic acid and RNA analysis applications, including single nucleotide polymorphism genotyping, copy number variations analysis, gene expression analysis, and methylation analysis, as well as allow the detection of known genetic markers on a single array. The company also provides various library preparation and sequencing kits to simplify workflows and accelerate analysis; and genome sequencing, genotyping, and noninvasive prenatal testing, as well as products support services. It serves genomic research centers, academic institutions, government laboratories, and hospitals; and pharmaceutical, biotechnology, agrigenomics, and commercial molecular diagnostic laboratories, as well as consumer genomics companies. The company markets and distributes its products directly to customers, as well as through life-science distributors. It operates in North America, Europe, Latin America, the Asia-Pacific region, the Middle East, and South Africa. Illumina, Inc. was founded in 1998 and is headquartered in San Diego, California.

Receive ILMN News and Ratings via Email

Sign-up to receive the latest news and ratings for ILMN and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry DRUGS
Sub-IndustryLife Sciences Tools & Services


Debt-to-Equity Ratio0.43%
Current Ratio3.99%
Quick Ratio3.55%


Trailing P/E Ratio51.1915322580645
Forward P/E Ratio55.32
P/E Growth3.36

Sales & Book Value

Annual Sales$2.75 billion
Price / Sales13.56
Cash Flow$5.32 per share
Price / Cash47.71
Book Value$18.83 per share
Price / Book13.48


Trailing EPS$4.96
Net Income$726 million
Net Margins26.56%
Return on Equity21.71%
Return on Assets11.94%


Outstanding Shares147,000,000

Illumina (NASDAQ:ILMN) Frequently Asked Questions

What is Illumina's stock symbol?

Illumina trades on the NASDAQ under the ticker symbol "ILMN."

How were Illumina's earnings last quarter?

Illumina (NASDAQ:ILMN) released its earnings results on Tuesday, January, 30th. The life sciences company reported $1.44 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $1.22 by $0.22. The life sciences company earned $778 million during the quarter, compared to analyst estimates of $752.04 million. Illumina had a net margin of 26.56% and a return on equity of 21.71%. The business's revenue was up 25.7% on a year-over-year basis. During the same period last year, the business earned $0.85 earnings per share. View Illumina's Earnings History.

When will Illumina make its next earnings announcement?

Illumina is scheduled to release their next quarterly earnings announcement on Monday, April, 23rd 2018. View Earnings Estimates for Illumina.

What guidance has Illumina issued on next quarter's earnings?

Illumina updated its FY18 earnings guidance on Tuesday, January, 30th. The company provided EPS guidance of $4.50-4.60 for the period, compared to the Thomson Reuters consensus EPS estimate of $4.58. The company issued revenue guidance of $3.10-3.13 billion, compared to the consensus revenue estimate of $3.13 billion.

Where is Illumina's stock going? Where will Illumina's stock price be in 2018?

20 brokerages have issued 12 month price objectives for Illumina's stock. Their forecasts range from $157.00 to $277.00. On average, they anticipate Illumina's share price to reach $242.18 in the next twelve months. View Analyst Ratings for Illumina.

What are Wall Street analysts saying about Illumina stock?

Here are some recent quotes from research analysts about Illumina stock:

  • 1. According to Zacks Investment Research, "Post a promising third-quarter show, we expect Illumina to maintain its growth momentum on continued uptake of sequencing consumables, instruments and microarray portfolios. Management is also hopeful that recent launches like NovaSeq S4 flow cell and reagent kit for its NovaSeq 6000 System will drive demand for NovaSeq. We look forward to the launch of NovaSeq Xp workflow. Also, the company’s launch of Nextera DNA Flex buoys optimism. Moreover, the company recently partnered with Telegraph Hill Partners to set up an independent entity. Accordingly, over the last three months, Illumina has been trading above the broader industry. On the flip side, weak margins owing to the NovaSeq launch, higher array services revenues and unfavorable product mix within sequencing consumables will continue to act as deterrents." (12/26/2017)
  • 2. Canaccord Genuity analysts commented, "Shipments to China grew +16% and we believe China is likely to be a double-digit grower for ILMN over the next several years, driven by the Chinese Precision Medicine Initiative," (8/7/2017)

Who are some of Illumina's key competitors?

Who are Illumina's key executives?

Illumina's management team includes the folowing people:

  • Mr. Jay T. Flatley, Exec. Chairman (Age 65)
  • Mr. Francis A. deSouza, CEO, Pres & Director (Age 47)
  • Mr. Omead Ostadan, Exec. VP of Operations, Products and Strategy (Age 46)
  • Dr. Mostafa Ronaghi Ph.D., Chief Technology Officer and Sr. VP (Age 49)
  • Mr. Marc A. Stapley, Chief Admin. Officer and Exec. VP (Age 48)

Has Illumina been receiving favorable news coverage?

Press coverage about ILMN stock has trended somewhat positive recently, according to Accern Sentiment. The research group rates the sentiment of news coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Illumina earned a coverage optimism score of 0.12 on Accern's scale. They also gave news coverage about the life sciences company an impact score of 44.94 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the next few days.

Who are Illumina's major shareholders?

Illumina's stock is owned by a variety of of retail and institutional investors. Top institutional investors include BAILLIE GIFFORD & COMPANY (12.16%), Sands Capital Management LLC (3.26%), Jennison Associates LLC (3.02%), Geode Capital Management LLC (1.08%), TIAA CREF Investment Management LLC (1.06%) and Winslow Capital Management LLC (0.72%). Company insiders that own Illumina stock include A Blaine Bowman, Charles Dadswell, Christian O Henry, Daniel Bradbury, David R Walt, Frances Arnold, Jay T Flatley, Karin Eastham, Marc Stapley, Michel Bouchard, Mostafa Ronaghi, Nicholas Naclerio, Oene Mark Van, Omead Ostadan, Paul L Bianchi, Robert S Epstein and Roy A Whitfield. View Institutional Ownership Trends for Illumina.

Which major investors are selling Illumina stock?

ILMN stock was sold by a variety of institutional investors in the last quarter, including Sands Capital Management LLC, Baird Financial Group Inc., Winslow Capital Management LLC, Renaissance Technologies LLC, Two Sigma Advisers LP, State Treasurer State of Michigan, Rockefeller Financial Services Inc. and Retirement Systems of Alabama. Company insiders that have sold Illumina company stock in the last year include A Blaine Bowman, Charles Dadswell, Daniel Bradbury, Frances Arnold, Jay T Flatley, Karin Eastham, Marc Stapley, Michel Bouchard, Mostafa Ronaghi, Oene Mark Van, Omead Ostadan and Robert S Epstein. View Insider Buying and Selling for Illumina.

Which major investors are buying Illumina stock?

ILMN stock was bought by a variety of institutional investors in the last quarter, including Jackson Square Partners LLC, Jennison Associates LLC, Assenagon Asset Management S.A., Carillon Tower Advisers Inc., Guggenheim Capital LLC, Arrowstreet Capital Limited Partnership, Teacher Retirement System of Texas and Geode Capital Management LLC. View Insider Buying and Selling for Illumina.

How do I buy shares of Illumina?

Shares of ILMN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Illumina's stock price today?

One share of ILMN stock can currently be purchased for approximately $253.91.

How big of a company is Illumina?

Illumina has a market capitalization of $37.32 billion and generates $2.75 billion in revenue each year. The life sciences company earns $726 million in net income (profit) each year or $4.96 on an earnings per share basis. Illumina employs 6,200 workers across the globe.

How can I contact Illumina?

Illumina's mailing address is 5200 ILLUMINA WAY, SAN DIEGO CA, 92122. The life sciences company can be reached via phone at 858-202-4500 or via email at [email protected]

MarketBeat Community Rating for Illumina (ILMN)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  727 (Vote Outperform)
Underperform Votes:  717 (Vote Underperform)
Total Votes:  1,444
MarketBeat's community ratings are surveys of what our community members think about Illumina and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Illumina (NASDAQ:ILMN) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyHold
Consensus Rating Score: 2.602.602.502.37
Ratings Breakdown: 1 Sell Rating(s)
6 Hold Rating(s)
13 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
6 Hold Rating(s)
13 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
8 Hold Rating(s)
11 Buy Rating(s)
0 Strong Buy Rating(s)
2 Sell Rating(s)
8 Hold Rating(s)
9 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $242.18$242.18$200.00$179.15
Price Target Upside: 4.62% downside9.99% upside6.96% downside16.26% downside

Illumina (NASDAQ:ILMN) Consensus Price Target History

Price Target History for Illumina (NASDAQ:ILMN)

Illumina (NASDAQ:ILMN) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/5/2018CitigroupUpgradeNeutral -> Buy$260.00 -> $275.00HighView Rating Details
1/31/2018BarclaysBoost Price TargetEqual Weight -> Equal Weight$200.00 -> $215.00MediumView Rating Details
1/31/2018Morgan StanleyBoost Price TargetUnderweight -> Underweight$145.00 -> $157.00HighView Rating Details
1/31/2018Leerink SwannBoost Price TargetOutperform -> Outperform$250.00 -> $276.00HighView Rating Details
1/31/2018Canaccord GenuityReiterated RatingBuy$255.00 -> $265.00HighView Rating Details
1/31/2018First AnalysisUpgradeEqual Weight -> Overweight$277.00HighView Rating Details
1/22/2018CowenBoost Price TargetOutperform$250.00 -> $275.00LowView Rating Details
1/16/2018BTIG ResearchReiterated RatingHoldLowView Rating Details
1/16/2018Deutsche BankSet Price TargetBuy$275.00MediumView Rating Details
1/9/2018Wells FargoReiterated RatingOutperform -> Positive$250.00 -> $260.00HighView Rating Details
1/9/2018Piper Jaffray CompaniesReiterated RatingBuy$269.00N/AView Rating Details
1/5/2018William BlairDowngradeOutperform -> Market PerformMediumView Rating Details
1/3/2018Evercore ISIInitiated CoverageOutperform$250.00LowView Rating Details
10/25/2017Bank of AmericaBoost Price TargetBuy$215.00 -> $240.00N/AView Rating Details
10/25/2017Robert W. BairdUpgradeNeutral -> Outperform$184.00 -> $228.00N/AView Rating Details
10/23/2017Janney Montgomery ScottUpgradeSell -> NeutralN/AView Rating Details
9/26/2017Goldman SachsReiterated RatingNeutral -> Neutral$200.00LowView Rating Details
9/13/2017ArgusBoost Price TargetBuy$205.00 -> $235.00LowView Rating Details
8/2/2017JPMorgan Chase & Co.Reiterated RatingOverweight$250.00HighView Rating Details
4/26/2017Cantor FitzgeraldBoost Price TargetNeutral -> Neutral$155.00 -> $170.00HighView Rating Details
1/6/2017CL KingUpgradeNeutral -> BuyN/AView Rating Details
7/27/2016MizuhoBoost Price TargetNeutral$138.00 -> $148.00N/AView Rating Details
5/4/2016Stifel NicolausReiterated RatingBuy$215.00 -> $160.00N/AView Rating Details
5/3/2016NomuraLower Price TargetBuy$210.00 -> $180.00N/AView Rating Details
4/22/2016Avondale PartnersReiterated RatingMarket Perform$175.00 -> $160.00N/AView Rating Details
(Data available from 3/19/2016 forward)


Illumina (NASDAQ:ILMN) Earnings History and Estimates Chart

Earnings by Quarter for Illumina (NASDAQ:ILMN)

Illumina (NASDAQ ILMN) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/23/2018$1.04N/AView Earnings Details
1/30/2018Q4 2017$1.22$1.44$752.04 million$778.00 millionViewListenView Earnings Details
10/24/2017Q3 2017$0.99$1.11$692.77 million$714.00 millionViewN/AView Earnings Details
8/1/2017Q2 2017$0.68$0.82$642.38 million$662.00 millionViewListenView Earnings Details
4/25/2017Q1 2017$0.64$0.64$590.51 million$598.00 millionViewN/AView Earnings Details
1/31/2017Q416$0.82$0.85$612.50 million$619.00 millionViewListenView Earnings Details
11/1/2016Q316$0.87$0.97$628.06 million$607.00 millionViewListenView Earnings Details
7/26/2016Q2$0.73$0.86$31.91 million$600.00 millionViewListenView Earnings Details
5/3/2016Q1$0.74$0.71$596.33 million$572.00 millionViewListenView Earnings Details
2/2/2016Q415$0.82$0.81$576.39 million$591.50 millionViewListenView Earnings Details
10/20/2015Q315$0.79$0.80$568.60 million$550.00 millionViewListenView Earnings Details
7/21/2015Q215$0.77$0.80$541.05 million$539.00 millionViewListenView Earnings Details
4/21/2015Q115$0.72$0.91$524.35 million$539.00 millionViewListenView Earnings Details
1/27/2015Q414$0.78$0.87$503.83 million$512.00 millionViewListenView Earnings Details
10/20/2014Q314$0.56$0.77$451.20 million$481.00 millionViewListenView Earnings Details
7/23/2014Q214$0.51$0.57$426.50 million$448.00 millionViewListenView Earnings Details
4/22/2014Q114$0.44$0.53$391.50 million$421.00 millionViewListenView Earnings Details
1/28/2014Q413$0.44$0.45$382.06 million$387.00 millionViewListenView Earnings Details
10/21/2013Q313$0.40$0.45$343.42 million$357.00 millionViewListenView Earnings Details
7/23/2013Q2 2013$0.40$0.43$331.77 million$346.09 millionViewListenView Earnings Details
4/22/2013Q1 2013$0.39$0.46$310.64 million$330.96 millionViewListenView Earnings Details
1/28/2013Q4 2012$0.41$0.42$303.13 million$309.30 millionViewListenView Earnings Details
10/23/2012$0.39$0.41ViewN/AView Earnings Details
7/24/2012$0.36$0.40ViewN/AView Earnings Details
4/23/2012$0.32$0.36ViewN/AView Earnings Details
2/7/2012$0.30$0.35ViewN/AView Earnings Details
10/25/2011$0.23$0.22ViewN/AView Earnings Details
7/26/2011Q2 2011$0.36$0.38ViewN/AView Earnings Details
4/26/2011$0.31$0.35ViewN/AView Earnings Details
2/8/2011$0.29$0.29ViewN/AView Earnings Details
10/26/2010Q3 2010$0.24$0.30ViewN/AView Earnings Details
7/27/2010Q2 2010$0.23$0.26ViewN/AView Earnings Details
4/28/2010Q1 2010$0.19$0.21ViewN/AView Earnings Details
2/4/2010Q4 2009$0.19$0.20ViewN/AView Earnings Details
10/27/2009Q3 2009$0.20$0.17ViewN/AView Earnings Details
7/21/2009Q2 2009$0.18$0.18ViewN/AView Earnings Details
4/21/2009Q1 2009$0.19$0.19ViewN/AView Earnings Details
2/3/2009Q4 2008$0.17$0.24ViewN/AView Earnings Details
10/21/2008Q3 2008$0.17$0.17ViewN/AView Earnings Details
7/22/2008Q2 2008$0.14$0.15ViewN/AView Earnings Details
4/22/2008Q1 2008$0.12$0.12ViewN/AView Earnings Details
2/4/2008Q4 2007$0.12$0.15ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)


Illumina (NASDAQ:ILMN) Earnings Estimates

2018 EPS Consensus Estimate: $4.59
2019 EPS Consensus Estimate: $5.19
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20183$0.88$1.09$1.00
Q2 20183$1.06$1.10$1.07
Q3 20183$1.14$1.26$1.20
Q4 20182$1.25$1.37$1.31
Q1 20192$1.03$1.19$1.11
Q2 20192$1.20$1.22$1.21
Q3 20192$1.35$1.43$1.39
Q4 20192$1.41$1.54$1.48
(Earnings estimates data provided by Zacks Investment Research)


Dividend History for Illumina (NASDAQ:ILMN)

No dividend announcements for this company have been tracked by

Insider Trades

Illumina (NASDAQ ILMN) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 0.89%
Institutional Ownership Percentage: 91.51%
Insider Trades by Quarter for Illumina (NASDAQ:ILMN)
Institutional Ownership by Quarter for Illumina (NASDAQ:ILMN)

Illumina (NASDAQ ILMN) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/15/2018Frances ArnoldDirectorSell250$252.26$63,065.0010,189View SEC Filing  
3/8/2018Frances ArnoldDirectorSell250$241.50$60,375.0010,439View SEC Filing  
3/5/2018Charles DadswellSVPSell145$227.17$32,939.657,991View SEC Filing  
3/5/2018Karin EasthamDirectorSell2,000$229.37$458,740.0015,288View SEC Filing  
3/2/2018Omead OstadanEVPSell1,329$222.66$295,915.1429,392View SEC Filing  
2/28/2018Robert S EpsteinDirectorSell250$231.25$57,812.507,088View SEC Filing  
2/16/2018Oene Mark VanSVPSell1,408$228.85$322,220.8015,760View SEC Filing  
2/6/2018Marc StapleyEVPSell2,000$216.87$433,740.0027,952View SEC Filing  
2/5/2018Charles DadswellSVPSell1,610$221.45$356,534.505,581View SEC Filing  
2/1/2018A Blaine BowmanDirectorSell3,000$230.82$692,460.0019,868View SEC Filing  
1/29/2018Robert S EpsteinDirectorSell1,250$244.18$305,225.008,588View SEC Filing  
1/17/2018Marc StapleyEVPSell2,000$242.33$484,660.0029,815View SEC Filing  
1/16/2018Jay T FlatleyDirectorSell15,000$243.72$3,655,800.00449,201View SEC Filing  
1/3/2018Charles DadswellSVPSell145$224.50$32,552.507,411View SEC Filing  
1/2/2018Jay T FlatleyDirectorSell20,000$223.40$4,468,000.00463,436View SEC Filing  
12/29/2017Robert S EpsteinDirectorSell1,250$217.38$271,725.00View SEC Filing  
12/29/2017Robert S EpsteinDirectorSell1,250$217.38$271,725.008,838View SEC Filing  
12/19/2017Jay T FlatleyDirectorSell20,000$215.48$4,309,600.00480,476View SEC Filing  
12/5/2017Jay T FlatleyDirectorSell20,000$212.55$4,251,000.00505,980View SEC Filing  
12/4/2017Charles DadswellSVPSell145$225.33$32,672.856,388View SEC Filing  
12/4/2017Marc StapleyEVPSell2,000$219.88$439,760.0029,198View SEC Filing  
12/1/2017Omead OstadanEVPSell3,540$226.91$803,261.4026,827View SEC Filing  
12/1/2017Robert S EpsteinDirectorSell1,250$226.55$283,187.509,088View SEC Filing  
11/21/2017Jay T FlatleyDirectorSell20,000$211.35$4,227,000.00531,717View SEC Filing  
11/15/2017Marc StapleyEVPSell2,000$205.48$410,960.0030,370View SEC Filing  
11/15/2017Oene Mark VanSVPSell1,250$207.76$259,700.0011,691View SEC Filing  
11/13/2017Oene Mark VanSVPSell1,232$207.78$255,984.9611,691View SEC Filing  
11/7/2017Jay T FlatleyDirectorSell20,000$210.59$4,211,800.00536,717View SEC Filing  
11/3/2017Charles DadswellSVPSell1,609$207.88$334,478.927,217View SEC Filing  
10/26/2017Marc StapleyEVPSell2,000$206.88$413,760.0034,579View SEC Filing  
10/24/2017Jay T FlatleyDirectorSell20,000$210.43$4,208,600.00539,176View SEC Filing  
10/12/2017Oene Mark VanSVPSell1,250$207.21$259,012.50View SEC Filing  
10/10/2017Jay T FlatleyDirectorSell20,000$203.27$4,065,400.00View SEC Filing  
10/3/2017Charles DadswellSVPSell145$202.23$29,323.35View SEC Filing  
9/26/2017Jay T FlatleyDirectorSell20,000$200.16$4,003,200.00539,176View SEC Filing  
9/12/2017Jay T FlatleyDirectorSell20,000$211.11$4,222,200.00539,176View SEC Filing  
9/12/2017Oene Mark VanSVPSell9,729$211.33$2,056,029.5724,908View SEC Filing  
9/7/2017Mostafa RonaghiSVPSell20,000$210.00$4,200,000.0086,725View SEC Filing  
9/5/2017Charles DadswellSVPSell145$205.71$29,827.95View SEC Filing  
9/5/2017Marc StapleyEVPSell2,000$205.93$411,860.0036,179View SEC Filing  
8/31/2017Michel BouchardInsiderSell5,390$202.11$1,089,372.9015,161View SEC Filing  
8/30/2017Michel BouchardCAOSell616$200.00$123,200.0015,161View SEC Filing  
8/29/2017Jay T FlatleyDirectorSell22,540$195.21$4,400,033.40539,176View SEC Filing  
8/28/2017Jay T FlatleyDirectorSell2,540$197.39$501,370.60539,176View SEC Filing  
8/15/2017Jay T FlatleyDirectorSell20,000$194.73$3,894,600.00539,176View SEC Filing  
8/7/2017Omead OstadanEVPSell1,671$195.26$326,279.4624,571View SEC Filing  
8/3/2017Charles DadswellSVPSell1,609$197.00$316,973.009,037View SEC Filing  
8/3/2017Marc StapleyEVPSell2,000$196.80$393,600.0037,941View SEC Filing  
8/2/2017Jay T FlatleyDirectorSell20,000$176.43$3,528,600.00534,176View SEC Filing  
8/2/2017Michel BouchardInsiderSell3,131$194.97$610,451.0715,777View SEC Filing  
8/2/2017Mostafa RonaghiSVPSell10,000$195.00$1,950,000.0076,585View SEC Filing  
7/18/2017Jay T FlatleyDirectorSell15,000$170.77$2,561,550.00534,176View SEC Filing  
7/14/2017Marc StapleyEVPSell2,000$173.56$347,120.0039,941View SEC Filing  
7/7/2017Omead OstadanEVPSell1,672$172.73$288,804.5626,242View SEC Filing  
7/5/2017Jay T FlatleyDirectorSell15,000$172.92$2,593,800.00534,176View SEC Filing  
7/3/2017Charles DadswellSVPSell145$174.24$25,264.8010,646View SEC Filing  
6/23/2017Michel BouchardInsiderSell246$185.00$45,510.0018,893View SEC Filing  
6/22/2017Jay T FlatleyDirectorSell20,000$178.21$3,564,200.00534,176View SEC Filing  
6/12/2017Marc StapleyEVPSell2,000$170.85$341,700.0041,341View SEC Filing  
6/8/2017Michel BouchardInsiderSell246$178.91$44,011.8619,139View SEC Filing  
6/6/2017Jay T FlatleyDirectorSell20,000$180.24$3,604,800.00539,176View SEC Filing  
6/5/2017Charles DadswellSVPSell145$184.75$26,788.7510,791View SEC Filing  
6/1/2017Jay T FlatleyDirectorSell3,320$180.55$599,426.00519,176View SEC Filing  
5/25/2017Frances ArnoldDirectorSell825$174.77$144,185.258,816View SEC Filing  
5/23/2017Jay T FlatleyDirectorSell15,000$175.53$2,632,950.00534,176View SEC Filing  
5/10/2017A Blaine BowmanDirectorSell2,300$181.61$417,703.0018,004View SEC Filing  
5/9/2017Jay T FlatleyDirectorSell20,000$184.14$3,682,800.00539,176View SEC Filing  
5/9/2017Michel BouchardInsiderSell5,740$184.68$1,060,063.2022,255View SEC Filing  
5/3/2017Charles DadswellSVPSell1,609$187.07$300,995.6310,936View SEC Filing  
4/12/2017A Blaine BowmanDirectorSell3,000$172.72$518,160.0018,704View SEC Filing  
4/7/2017Daniel BradburyDirectorSell600$172.79$103,674.0017,065View SEC Filing  
3/24/2017Omead OstadanEVPSell1,672$170.00$284,240.0029,586View SEC Filing  
3/21/2017Daniel BradburyDirectorSell600$163.56$98,136.0017,065View SEC Filing  
2/17/2017Daniel BradburyDirectorSell600$162.80$97,680.0017,065View SEC Filing  
2/13/2017Omead OstadanEVPSell2,173$163.10$354,416.30View SEC Filing  
2/8/2017A Blaine BowmanDirectorSell3,000$162.74$488,220.0016,204View SEC Filing  
2/6/2017Charles DadswellSVPSell572$161.26$92,240.727,592View SEC Filing  
1/30/2017Omead OstadanEVPSell259$160.90$41,673.1027,949View SEC Filing  
1/19/2017Omead OstadanEVPSell2,378$160.06$380,622.6829,040View SEC Filing  
1/11/2017A Blaine BowmanDirectorSell3,000$162.89$488,670.0018,704View SEC Filing  
1/10/2017Charles DadswellSVPSell116$161.60$18,745.60View SEC Filing  
1/4/2017Daniel BradburyDirectorSell600$135.01$81,006.0017,065View SEC Filing  
12/15/2016Omead OstadanEVPSell2,000$126.16$252,320.00View SEC Filing  
12/12/2016Daniel BradburyDirectorSell600$123.42$74,052.0017,065View SEC Filing  
12/8/2016Omead OstadanEVPSell3,000$121.63$364,890.0052,988View SEC Filing  
12/1/2016Omead OstadanEVPSell3,000$133.30$399,900.0051,492View SEC Filing  
11/14/2016Daniel BradburyDirectorSell600$136.34$81,804.0017,065View SEC Filing  
10/7/2016Daniel BradburyDirectorSell600$184.36$110,616.0017,065View SEC Filing  
10/4/2016Charles DadswellSVPSell116$182.38$21,156.0839,900View SEC Filing  
9/20/2016Robert S EpsteinDirectorSell300$174.29$52,287.006,924View SEC Filing  
9/15/2016Marc StapleyEVPSell1,270$172.87$219,544.9033,916View SEC Filing  
9/14/2016Daniel BradburyDirectorSell600$171.25$102,750.0017,065View SEC Filing  
8/23/2016Jay T FlatleyDirectorSell20,000$172.99$3,459,800.00508,061View SEC Filing  
8/22/2016Robert S EpsteinDirectorSell300$170.27$51,081.007,224View SEC Filing  
8/17/2016Daniel BradburyDirectorSell600$168.42$101,052.0017,065View SEC Filing  
8/15/2016Jay T FlatleyDirectorSell10,000$170.00$1,700,000.00498,061View SEC Filing  
8/12/2016Roy A WhitfieldDirectorSell4,000$167.22$668,880.006,853View SEC Filing  
8/9/2016Jay T FlatleyDirectorSell10,000$165.97$1,659,700.00498,061View SEC Filing  
8/1/2016Jay T FlatleyDirectorSell10,000$170.00$1,700,000.00498,061View SEC Filing  
7/27/2016Charles DadswellSVPSell8,632$155.00$1,337,960.0040,248View SEC Filing  
7/26/2016Jay T FlatleyDirectorSell10,000$150.00$1,500,000.00498,061View SEC Filing  
7/20/2016Robert S EpsteinDirectorSell1,200$150.00$180,000.007,824View SEC Filing  
7/18/2016Jay T FlatleyDirectorSell10,000$150.00$1,500,000.00498,061View SEC Filing  
7/14/2016A Blaine BowmanDirectorSell5,000$147.14$735,700.0020,704View SEC Filing  
7/11/2016Christian O HenryEVPSell716$141.89$101,593.2418,976View SEC Filing  
6/16/2016A Blaine BowmanDirectorSell5,000$135.08$675,400.0020,704View SEC Filing  
6/15/2016Christian O HenryEVPSell2,141$137.90$295,243.9020,213View SEC Filing  
6/13/2016Roy A WhitfieldDirectorSell3,800$140.44$533,672.006,653View SEC Filing  
6/1/2016Karin EasthamDirectorSell5,000$145.35$726,750.0017,424View SEC Filing  
5/25/2016Christian O HenryEVPSell2,141$144.73$309,866.9322,463View SEC Filing  
5/17/2016Christian O HenryEVPSell2,141$140.84$301,538.4424,174View SEC Filing  
5/12/2016A Blaine BowmanDirectorSell5,000$137.11$685,550.0018,615View SEC Filing  
4/27/2016Christian O HenryEVPSell2,141$138.46$296,442.8627,073View SEC Filing  
4/18/2016Christian O HenryEVPSell2,141$176.01$376,837.4129,889View SEC Filing  
4/18/2016Paul L BianchiVPSell1,884$175.00$329,700.0065,660View SEC Filing  
4/14/2016A Blaine BowmanDirectorSell5,000$172.94$864,700.0018,615View SEC Filing  
4/13/2016Christian O HenryEVPSell12,500$175.00$2,187,500.0042,897View SEC Filing  
4/13/2016Paul L BianchiVPSell6,681$175.00$1,169,175.0067,544View SEC Filing  
4/12/2016Jay T FlatleyCEOSell20,000$170.05$3,401,000.00508,061View SEC Filing  
4/12/2016Roy A WhitfieldDirectorSell4,000$170.00$680,000.005,800View SEC Filing  
4/7/2016David R WaltDirectorSell4,000$168.90$675,600.00635,840View SEC Filing  
4/5/2016Christian O HenryEVPSell2,141$166.07$355,555.8731,997View SEC Filing  
4/4/2016Charles DadswellSVPSell8,382$167.81$1,406,583.4254,970View SEC Filing  
3/23/2016Christian O HenryEVPSell2,141$155.05$331,962.0533,738View SEC Filing  
3/22/2016Jay T FlatleyCEOSell10,000$154.18$1,541,800.00498,061View SEC Filing  
3/21/2016Daniel BradburyDirectorSell1,200$155.63$186,756.0015,576View SEC Filing  
3/21/2016Nicholas NaclerioSVPSell4,520$154.25$697,210.0030,020View SEC Filing  
3/17/2016A Blaine BowmanDirectorSell5,000$145.24$726,200.0018,615View SEC Filing  
3/15/2016David R WaltDirectorSell4,000$149.99$599,960.00635,840View SEC Filing  
3/14/2016Christian O HenryEVPSell5,892$155.91$918,621.7238,529View SEC Filing  
3/8/2016Charles DadswellSVPSell8,382$155.63$1,304,490.6666,507View SEC Filing  
3/8/2016Jay T FlatleyCEOSell10,000$154.49$1,544,900.00500,915View SEC Filing  
3/8/2016Omead OstadanEVPSell4,516$156.09$704,902.4460,576View SEC Filing  
3/7/2016Charles DadswellSVPSell116$155.00$17,980.0066,507View SEC Filing  
2/23/2016Jay T FlatleyCEOSell10,000$152.49$1,524,900.00440,784View SEC Filing  
2/17/2016Daniel BradburyDirectorSell1,700$154.74$263,058.0014,376View SEC Filing  
2/12/2016Roy A. WhitfieldDirectorSell3,750$140.30$526,125.001,800View SEC Filing  
2/1/2016Omead OstadanEVPSell1,108$156.73$173,656.8446,476View SEC Filing  
1/26/2016Jay T. FlatleyCEOSell20,000$171.70$3,434,000.00433,423View SEC Filing  
1/13/2016Jay T. FlatleyCEOSell20,000$168.81$3,376,200.00433,423View SEC Filing  
1/4/2016Daniel BradburyDirectorSell1,700$182.80$310,760.0014,376View SEC Filing  
12/28/2015Charles DadswellSVPSell168$188.63$31,689.8441,830View SEC Filing  
12/22/2015Jay T. FlatleyCEOSell25,000$185.38$4,634,500.00433,423View SEC Filing  
12/14/2015Roy A. WhitfieldDirectorSell3,750$175.07$656,512.5013,648View SEC Filing  
12/11/2015Omead OstadanEVPSell260$179.90$46,774.0048,293View SEC Filing  
12/11/2015Paul L BianchiVPSell197$179.90$35,440.3059,827View SEC Filing  
12/10/2015Daniel BradburyDirectorSell1,700$182.37$310,029.0014,376View SEC Filing  
12/8/2015Jay T. FlatleyCEOSell25,000$177.11$4,427,750.00433,423View SEC Filing  
11/27/2015Robert S EpsteinDirectorSell1,000$185.56$185,560.006,935View SEC Filing  
11/25/2015Jay T. FlatleyCEOSell5,000$180.00$900,000.00423,793View SEC Filing  
11/24/2015Jay T. FlatleyCEOSell20,000$173.27$3,465,400.00423,793View SEC Filing  
11/16/2015Jay T. FlatleyCEOSell10,000$170.00$1,700,000.00423,793View SEC Filing  
11/10/2015Daniel BradburyDirectorSell1,700$154.03$261,851.0014,376View SEC Filing  
11/10/2015Jay T. FlatleyCEOSell10,000$154.58$1,545,800.00423,793View SEC Filing  
11/3/2015Charles DadswellSVPSell158$150.00$23,700.0040,847View SEC Filing  
10/15/2015Jay T. FlatleyCEOSell10,000$150.00$1,500,000.00424,996View SEC Filing  
10/7/2015Daniel BradburyDirectorSell1,700$145.81$247,877.0014,376View SEC Filing  
9/29/2015David R WaltDirectorSell2,000$171.65$343,300.00648,840View SEC Filing  
9/22/2015Jay T. FlatleyCEOSell25,000$192.79$4,819,750.00424,996View SEC Filing  
9/15/2015David R WaltDirectorSell2,000$206.45$412,900.00648,840View SEC Filing  
9/14/2015Daniel BradburyDirectorSell1,700$203.89$346,613.0014,376View SEC Filing  
9/9/2015Paul L. BianchiVPSell1,245$199.32$248,153.4058,519View SEC Filing  
9/8/2015Jay T. FlatleyCEOSell25,000$194.87$4,871,750.00424,996View SEC Filing  
9/8/2015Karin EasthamDirectorSell4,300$195.76$841,768.0010,419View SEC Filing  
9/4/2015Roy A. WhitfieldDirectorSell4,500$192.63$866,835.0013,648View SEC Filing  
9/1/2015David R WaltDirectorSell2,000$195.08$390,160.00648,840View SEC Filing  
8/27/2015Jay T. FlatleyCEOSell25,000$200.16$5,004,000.00424,996View SEC Filing  
8/18/2015David R WaltDirectorSell2,000$206.89$413,780.00View SEC Filing  
8/17/2015Daniel BradburyDirectorSell1,700$208.14$353,838.00View SEC Filing  
8/13/2015Jay T FlatleyCEOSell25,000$207.85$5,196,250.00View SEC Filing  
8/5/2015Roy A. WhitfieldDirectorSell4,500$215.22$968,490.0013,648View SEC Filing  
7/24/2015A Blaine BowmanDirectorSell3,000$221.47$664,410.00View SEC Filing  
7/23/2015Jay T FlatleyCEOSell25,000$214.87$5,371,750.00View SEC Filing  
7/21/2015David R WaltDirectorSell12,000$235.24$2,822,880.00View SEC Filing  
7/17/2015Mostafa RonaghiSVPSell1,200$235.00$282,000.00View SEC Filing  
7/16/2015Christian O HenrySVPSell5,390$229.61$1,237,597.90View SEC Filing  
7/15/2015Mostafa RonaghiSVPSell3,000$227.19$681,570.00View SEC Filing  
7/14/2015David R WaltDirectorSell10,000$227.39$2,273,900.00View SEC Filing  
7/13/2015Marc StapleyCFOSell3,000$214.90$644,700.00View SEC Filing  
7/13/2015Michel BouchardCAOSell1,400$222.75$311,850.00View SEC Filing  
7/10/2015Omead OstadanSVPSell1,110$219.81$243,989.10View SEC Filing  
7/10/2015Robert S EpsteinDirectorSell2,000$219.81$439,620.00View SEC Filing  
7/9/2015Jay T FlatleyCEOSell25,000$218.10$5,452,500.00View SEC Filing  
7/7/2015David R WaltDirectorSell10,000$220.22$2,202,200.00View SEC Filing  
7/6/2015Daniel BradburyDirectorSell1,700$219.70$373,490.00View SEC Filing  
6/30/2015David R WaltDirectorSell10,000$217.64$2,176,400.00View SEC Filing  
6/25/2015Jay T FlatleyCEOSell25,000$220.34$5,508,500.00View SEC Filing  
6/24/2015A Blaine BowmanDirectorSell3,000$221.43$664,290.00View SEC Filing  
6/24/2015Christian O HenrySVPSell5,084$221.07$1,123,919.88View SEC Filing  
6/23/2015David R WaltDirectorSell12,000$220.11$2,641,320.00View SEC Filing  
6/17/2015Christian O HenrySVPSell3,751$215.71$809,128.21View SEC Filing  
6/16/2015David R WaltDirectorSell10,000$215.14$2,151,400.00View SEC Filing  
6/15/2015Nicholas NaclerioSVPSell6,590$214.33$1,412,434.70View SEC Filing  
6/15/2015Paul L BianchiVPSell3,408$215.83$735,548.64View SEC Filing  
6/12/2015Marc StapleyCFOSell3,000$214.90$644,700.00View SEC Filing  
6/12/2015Michel BouchardCAOSell1,400$216.11$302,554.00View SEC Filing  
6/11/2015Jay T FlatleyCEOSell25,000$216.41$5,410,250.00View SEC Filing  
6/10/2015Christian O HenrySVPSell10,000$214.94$2,149,400.00View SEC Filing  
6/10/2015Robert S EpsteinDirectorSell2,000$214.24$428,480.00View SEC Filing  
6/5/2015Roy A WhitfieldDirectorSell4,500$207.49$933,705.00View SEC Filing  
6/2/2015David R WaltDirectorSell10,000$204.42$2,044,200.00View SEC Filing  
6/1/2015Karin EasthamDirectorSell5,000$205.24$1,026,200.00View SEC Filing  
5/29/2015Daniel BradburyDirectorSell1,700$206.62$351,254.00View SEC Filing  
5/28/2015Jay T FlatleyCEOSell25,000$208.78$5,219,500.00View SEC Filing  
5/22/2015A Blaine BowmanDirectorSell3,000$204.58$613,740.00View SEC Filing  
5/19/2015David R WaltDirectorSell10,000$202.00$2,020,000.00View SEC Filing  
5/14/2015Christian O HenrySVPSell3,751$198.52$744,648.52View SEC Filing  
5/14/2015Jay T FlatleyCEOSell25,000$197.76$4,944,000.00View SEC Filing  
5/13/2015Paul L BianchiVPSell3,356$197.14$661,601.84View SEC Filing  
5/11/2015Robert S EpsteinDirectorSell2,000$196.49$392,980.00View SEC Filing  
4/28/2015David R WaltDirectorSell7,000$183.88$1,287,160.00View SEC Filing  
4/24/2015A Blaine BowmanDirectorSell3,000$190.73$572,190.00View SEC Filing  
4/23/2015Jay T FlatleyCEOSell25,000$189.57$4,739,250.00View SEC Filing  
4/21/2015David R WaltDirectorSell10,000$197.95$1,979,500.00View SEC Filing  
4/15/2015Christian O HenrySVPSell3,751$189.02$709,014.02View SEC Filing  
4/14/2015David R WaltDirectorSell7,000$188.23$1,317,610.00View SEC Filing  
4/13/2015Marc StapleyCFOSell3,000$190.12$570,360.00View SEC Filing  
4/13/2015Michel BouchardCAOSell1,400$188.61$264,054.00View SEC Filing  
4/13/2015Paul L BianchiVPSell3,390$187.22$634,675.80View SEC Filing  
4/10/2015Robert S EpsteinDirectorSell2,000$186.99$373,980.00View SEC Filing  
4/9/2015Jay T FlatleyCEOSell25,000$184.55$4,613,750.00View SEC Filing  
4/8/2015Daniel BradburyDirectorSell1,700$185.32$315,044.00View SEC Filing  
4/7/2015David R WaltDirectorSell5,000$184.28$921,400.00View SEC Filing  
4/6/2015Roy A WhitfieldDirectorSell4,600$181.32$834,072.00View SEC Filing  
3/26/2015Jay T FlatleyCEOSell25,000$181.34$4,533,500.00View SEC Filing  
3/24/2015David R WaltDirectorSell5,000$192.16$960,800.00View SEC Filing  
3/17/2015A Blaine BowmanDirectorSell3,000$192.30$576,900.00View SEC Filing  
3/16/2015Gerald MoellerDirectorSell2,700$193.36$522,072.00View SEC Filing  
3/16/2015Nicholas NaclerioSVPSell6,590$193.94$1,278,064.60View SEC Filing  
3/13/2015Paul L BianchiVPSell3,390$186.67$632,811.30View SEC Filing  
3/12/2015Marc StapleyCFOSell3,314$189.01$626,379.14View SEC Filing  
3/10/2015Richard KlausnerSVPSell1,186$191.75$227,415.50View SEC Filing  
3/10/2015Robert S EpsteinDirectorSell3,000$191.75$575,250.00View SEC Filing  
2/26/2015Jay T FlatleyCEOSell25,000$195.73$4,893,250.00View SEC Filing  
2/12/2015Jay T FlatleyCEOSell25,000$194.64$4,866,000.00View SEC Filing  
2/3/2015David R WaltDirectorSell7,000$190.89$1,336,230.00View SEC Filing  
2/2/2015Karin EasthamDirectorSell10,000$192.77$1,927,700.00View SEC Filing  
2/2/2015Nicholas NaclerioSVPSell15,250$194.37$2,964,142.50View SEC Filing  
1/27/2015Charles DadswellSVPSell224$198.90$44,553.60View SEC Filing  
1/27/2015David R WaltDirectorSell4,000$201.76$807,040.00View SEC Filing  
1/22/2015Jay T FlatleyCEOSell25,000$188.48$4,712,000.00View SEC Filing  
1/20/2015William H RastetterDirectorSell16,000$188.99$3,023,840.00View SEC Filing  
1/15/2015Marc StapleyCFOSell1,422$181.62$258,263.64View SEC Filing  
1/8/2015Jay T FlatleyCEOSell25,000$197.62$4,940,500.00View SEC Filing  
1/6/2015David R WaltDirectorSell6,000$188.55$1,131,300.00View SEC Filing  
1/2/2015Karin EasthamDirectorSell10,000$185.63$1,856,300.00View SEC Filing  
12/30/2014David R WaltDirectorSell5,000$186.95$934,750.00View SEC Filing  
12/29/2014Gerald MoellerDirectorSell8,000$187.05$1,496,400.00View SEC Filing  
12/26/2014Jay T FlatleyCEOSell25,000$186.71$4,667,750.00View SEC Filing  
12/23/2014David R WaltDirectorSell7,000$184.55$1,291,850.00View SEC Filing  
12/16/2014David R WaltDirectorSell5,000$178.35$891,750.00View SEC Filing  
12/15/2014Marc StapleyCFOSell1,422$181.09$257,509.98View SEC Filing  
12/11/2014Jay T FlatleyCEOSell25,000$185.79$4,644,750.00View SEC Filing  
12/9/2014David R WaltDirectorSell7,000$186.75$1,307,250.00View SEC Filing  
12/8/2014Daniel BradburyDirectorSell1,600$190.14$304,224.00View SEC Filing  
12/4/2014Karin EasthamDirectorSell10,000$191.87$1,918,700.00View SEC Filing  
12/1/2014Mostafa RonaghiSVPSell10,000$188.46$1,884,600.00View SEC Filing  
11/26/2014Paul L BianchiSVPSell1,626$189.20$307,639.20View SEC Filing  
11/17/2014Roy A WhitfieldDirectorSell4,000$178.26$713,040.00View SEC Filing  
11/14/2014Marc StapleyCFOSell1,422$181.13$257,566.86View SEC Filing  
11/13/2014Daniel BradburyDirectorSell2,100$186.88$392,448.00View SEC Filing  
11/13/2014Jay T FlatleyCEOSell25,000$189.32$4,733,000.00View SEC Filing  
11/3/2014Michel BouchardCAOSell631$195.68$123,474.08View SEC Filing  
11/3/2014Mostafa RonaghiSVPSell10,000$195.66$1,956,600.00View SEC Filing  
10/30/2014Daniel BradburyDirectorSell2,100$191.83$402,843.00View SEC Filing  
10/23/2014Jay T FlatleyCEOSell25,000$189.54$4,738,500.00View SEC Filing  
10/13/2014Daniel BradburyDirectorSell2,100$152.03$319,263.00View SEC Filing  
10/9/2014Jay T FlatleyCEOSell25,000$163.49$4,087,250.00View SEC Filing  
10/7/2014A Blaine BowmanDirectorSell4,456$159.51$710,776.56View SEC Filing  
10/1/2014Daniel BradburyDirectorSell2,100$158.88$333,648.00View SEC Filing  
10/1/2014Mostafa RonaghiSVPSell10,000$159.81$1,598,100.00View SEC Filing  
9/30/2014A Blaine BowmanDirectorSell5,000$164.02$820,100.00View SEC Filing  
9/29/2014Gerald MoellerDirectorSell5,000$164.89$824,450.00View SEC Filing  
9/25/2014Jay T FlatleyCEOSell25,000$164.43$4,110,750.00View SEC Filing  
9/24/2014Christian O HenrySVPSell20,000$167.28$3,345,600.00View SEC Filing  
9/23/2014A Blaine BowmanDirectorSell5,000$168.50$842,500.00View SEC Filing  
9/16/2014A Blaine BowmanDirectorSell5,000$169.60$848,000.00View SEC Filing  
9/15/2014Daniel BradburyDirectorSell2,100$168.57$353,997.00View SEC Filing  
9/15/2014Jay T FlatleyCEOSell25,000$176.06$4,401,500.00View SEC Filing  
9/15/2014Marc StapleyCFOSell1,422$169.05$240,389.10View SEC Filing  
9/15/2014Nicholas NaclerioSVPSell2,000$169.53$339,060.00View SEC Filing  
9/9/2014A Blaine BowmanDirectorSell5,000$178.08$890,400.00View SEC Filing  
9/3/2014Christian O HenrySVPSell10,000$180.59$1,805,900.00View SEC Filing  
9/3/2014Daniel BradburyDirectorSell2,100$179.77$377,517.00View SEC Filing  
9/2/2014A Blaine BowmanDirectorSell5,000$179.67$898,350.00View SEC Filing  
9/2/2014Michel BouchardVPSell686$180.07$123,528.02View SEC Filing  
9/2/2014Mostafa RonaghiSVPSell10,000$179.66$1,796,600.00View SEC Filing  
8/28/2014Jay T FlatleyCEOSell30,000$178.98$5,369,400.00View SEC Filing  
8/26/2014A Blaine BowmanDirectorSell5,000$179.22$896,100.00View SEC Filing  
8/22/2014Daniel BradburyDirectorSell2,100$172.24$361,704.00View SEC Filing  
8/19/2014A Blaine BowmanDirectorSell5,000$171.70$858,500.00View SEC Filing  
8/15/2014Nicholas NaclerioSVPSell2,000$167.23$334,460.00View SEC Filing  
8/15/2014Roy A WhitfieldDirectorSell4,000$169.28$677,120.00View SEC Filing  
8/13/2014Christian O HenrySVPSell20,000$164.66$3,293,200.00View SEC Filing  
8/5/2014A Blaine BowmanDirectorSell5,000$159.91$799,550.00View SEC Filing  
8/4/2014Daniel BradburyDirectorSell2,100$159.77$335,517.00View SEC Filing  
8/1/2014Mostafa RonaghiSVPSell10,000$159.73$1,597,300.00View SEC Filing  
7/29/2014A Blaine BowmanDirectorSell5,000$166.89$834,450.00View SEC Filing  
7/29/2014Christian O HenrySVPSell10,000$167.40$1,674,000.00View SEC Filing  
7/24/2014Jay T FlatleyCEOSell30,000$175.43$5,262,900.00View SEC Filing  
7/23/2014Daniel BradburyDirectorSell2,100$177.87$373,527.00View SEC Filing  
7/15/2014Nicholas NaclerioSVPSell2,000$174.26$348,520.00View SEC Filing  
7/14/2014Marc StapleyCFOSell1,422$177.59$252,532.98View SEC Filing  
7/10/2014Jay T FlatleyCEOSell30,000$172.56$5,176,800.00View SEC Filing  
7/8/2014Daniel BradburyDirectorSell2,100$172.89$363,069.00View SEC Filing  
7/1/2014Mostafa RonaghiSVPSell10,000$179.47$1,794,700.00View SEC Filing  
6/30/2014Gerald MoellerDirectorSell5,000$178.97$894,850.00View SEC Filing  
6/27/2014Daniel BradburyDirectorSell2,100$171.65$360,465.00View SEC Filing  
6/26/2014Jay T FlatleyCEOSell30,000$170.11$5,103,300.00View SEC Filing  
6/24/2014Christian O HenrySVPSell10,000$172.60$1,726,000.00View SEC Filing  
6/16/2014Christian O HenrySVPSell20,000$169.73$3,394,600.00View SEC Filing  
6/16/2014Marc StapleyCFOSell1,422$169.25$240,673.50View SEC Filing  
6/12/2014Daniel BradburyDirectorSell2,100$171.17$359,457.00View SEC Filing  
6/12/2014Jay T FlatleyCEOSell30,000$172.25$5,167,500.00View SEC Filing  
6/2/2014Karin EasthamDirectorSell6,000$157.56$945,360.00View SEC Filing  
6/2/2014Michel BouchardCAOSell1,491$155.51$231,865.41View SEC Filing  
6/2/2014Mostafa RonaghiSVPSell10,000$156.93$1,569,300.00View SEC Filing  
5/22/2014Jay FlatleyCEOSell30,000$154.95$4,648,500.00381,262View SEC Filing  
5/15/2014Nicholas NaclerioSVPSell2,000$141.72$283,440.0023,146View SEC Filing  
5/15/2014Roy WhitfieldDirectorSell4,000$143.71$574,840.009,196View SEC Filing  
5/14/2014Daniel BradburyDirectorSell2,100$146.46$307,566.009,924View SEC Filing  
5/14/2014Marc StapleyCFOSell1,422$146.94$208,948.6821,996View SEC Filing  
5/8/2014Jay FlatleyCEOSell30,000$143.59$4,307,700.00381,262View SEC Filing  
5/2/2014Daniel BradburyDirectorSell2,100$139.66$293,286.009,924View SEC Filing  
5/1/2014Mostafa RonaghiSVPSell10,000$135.91$1,359,100.0028,604View SEC Filing  
4/24/2014Jay FlatleyCEOSell30,000$150.80$4,524,000.00381,262View SEC Filing  
4/15/2014Daniel BradburyDirectorSell2,100$131.29$275,709.009,924View SEC Filing  
4/15/2014Nicholas NaclerioSVPSell2,000$133.56$267,120.0023,146View SEC Filing  
4/14/2014Marc StapleyCFOSell1,422$134.80$191,685.6021,996View SEC Filing  
4/10/2014Jay FlatleyCEOSell30,000$139.90$4,197,000.00381,262View SEC Filing  
4/4/2014Daniel BradburyDirectorSell2,100$138.44$290,724.009,924View SEC Filing  
4/1/2014Mostafa RonaghiSVPSell10,000$152.41$1,524,100.0028,604View SEC Filing  
3/27/2014Jay FlatleyCEOSell30,000$140.11$4,203,300.00381,262View SEC Filing  
3/19/2014Daniel BradburyDirectorSell2,100$161.14$338,394.009,924View SEC Filing  
3/17/2014Gerald MoellerDirectorSell10,000$161.92$1,619,200.0014,620View SEC Filing  
3/17/2014Nicholas NaclerioSVPSell2,000$163.65$327,300.0023,146View SEC Filing  
3/14/2014Marc StapleyCFOSell1,422$163.35$232,283.7021,996View SEC Filing  
3/13/2014Jay FlatleyCEOSell30,000$165.96$4,978,800.00381,262View SEC Filing  
3/11/2014Christian HenrySVPSell3,000$167.16$501,480.0028,519View SEC Filing  
3/11/2014Michel BouchardCAOSell2,168$167.21$362,511.2825,049View SEC Filing  
3/3/2014Michel BouchardCAOSell2,994$176.81$529,369.1429,580View SEC Filing  
2/25/2014Michel BouchardCAOSell24,505$176.13$4,316,065.6529,580View SEC Filing  
2/24/2014Roy WhitfieldDirectorSell2,000$175.26$350,520.009,196View SEC Filing  
2/18/2014Nicholas NaclerioSVPSell2,000$169.77$339,540.0025,781View SEC Filing  
2/13/2014Jay FlatleyCEOSell30,000$160.43$4,812,900.00385,105View SEC Filing  
2/7/2014Jay FlatleyCEOSell5,000$152.23$761,150.00398,105View SEC Filing  
1/31/2014Marc StapleyCFOSell20,038$151.32$3,032,150.1621,797View SEC Filing  
1/23/2014Jay FlatleyCEOSell30,000$142.30$4,269,000.00399,509View SEC Filing  
1/9/2014Jay FlatleyCEOSell30,000$114.77$3,443,100.00399,509View SEC Filing  
12/26/2013Jay FlatleyCEOSell30,000$107.88$3,236,400.00399,509View SEC Filing  
12/17/2013Gregory HeathSVPSell1,875$102.68$192,525.0026,740View SEC Filing  
10/30/2013Christian O HenrySVPSell6,000$93.29$559,740.00View SEC Filing  
10/30/2013David R WaltDirectorSell5,000$93.02$465,100.00View SEC Filing  
10/28/2013William H RastetterDirectorSell20,000$92.37$1,847,400.00View SEC Filing  
10/24/2013Jay T FlatleyCEOSell30,000$92.32$2,769,600.00View SEC Filing  
10/22/2013Nicholas NaclerioSVPSell20,000$90.00$1,800,000.00View SEC Filing  
10/17/2013Gregory HeathSVPSell1,875$82.09$153,918.75View SEC Filing  
10/16/2013David R WaltDirectorSell5,000$82.59$412,950.00View SEC Filing  
10/15/2013Nicholas NaclerioSVPSell4,000$81.32$325,280.00View SEC Filing  
10/10/2013Christian HenrySVPSell6,000$77.73$466,380.0030,236View SEC Filing  
10/10/2013Jay FlatleyCEOSell20,000$77.75$1,555,000.00399,509View SEC Filing  
10/2/2013David R WaltDirectorSell5,000$80.58$402,900.00View SEC Filing  
9/18/2013David WaltDirectorSell5,000$83.11$415,550.00926,488View SEC Filing  
9/17/2013Gregory HeathSVPSell1,875$85.20$159,750.0026,740View SEC Filing  
9/16/2013Jay FlatleyCEOSell30,000$83.27$2,498,100.00399,509View SEC Filing  
9/16/2013Nicholas NaclerioSVPSell4,000$85.00$340,000.0024,559View SEC Filing  
9/10/2013Gregory HeathSVPSell1,875$82.00$153,750.00View SEC Filing  
9/9/2013Paul L BianchiSVPSell1,627$79.03$128,581.81View SEC Filing  
9/5/2013Christian O HenrySVPSell9,000$78.17$703,530.00View SEC Filing  
9/4/2013David R WaltDirectorSell5,000$77.18$385,900.00View SEC Filing  
9/3/2013Nicholas NaclerioSVPSell59,000$76.91$4,537,690.00View SEC Filing  
9/3/2013Roy A WhitfieldDirectorSell2,000$78.49$156,980.00View SEC Filing  
8/30/2013Mark LewisSVPSell5,000$78.12$390,600.0044,837View SEC Filing  
8/22/2013Jay FlatleyCEOSell20,000$78.65$1,573,000.00399,509View SEC Filing  
8/21/2013David WaltDirectorSell5,000$78.34$391,700.00936,488View SEC Filing  
8/15/2013Nicholas NaclerioSVPSell2,000$78.43$156,860.0024,559View SEC Filing  
8/8/2013Jay FlatleyCEOSell20,000$78.07$1,561,400.00399,509View SEC Filing  
8/7/2013David WaltDirectorSell5,000$78.29$391,450.00941,488View SEC Filing  
8/2/2013Michel BouchardVPSell11,465$80.64$924,537.60View SEC Filing  
7/25/2013Christian O HenrySVPSell11,462$80.89$927,161.18View SEC Filing  
7/25/2013Jay T FlatleyCEOSell20,000$81.01$1,620,200.00View SEC Filing  
7/24/2013David R WaltDirectorSell4,600$81.44$374,624.00View SEC Filing  
7/24/2013Gregory HeathSVPSell209,533$82.00$17,181,706.00View SEC Filing  
7/24/2013Michel BouchardVPSell9,789$79.28$776,071.92View SEC Filing  
7/15/2013Nicholas NaclerioSVPSell2,000$74.50$149,000.00View SEC Filing  
7/11/2013Jay T FlatleyCEOSell20,000$74.90$1,498,000.00View SEC Filing  
7/11/2013Mostafa RonaghiSVPSell24,000$74.95$1,798,800.00View SEC Filing  
7/10/2013David R WaltDirectorSell5,000$74.26$371,300.00View SEC Filing  
7/10/2013Michel BouchardVPSell3,618$74.30$268,817.40View SEC Filing  
7/9/2013Christian O HenrySVPSell9,000$74.01$666,090.00View SEC Filing  
6/27/2013Jay T FlatleyCEOSell20,000$74.96$1,499,200.00View SEC Filing  
6/26/2013David R WaltDirectorSell5,000$75.36$376,800.00View SEC Filing  
6/26/2013Michel BouchardVPSell4,272$75.06$320,656.32View SEC Filing  
6/25/2013Tristan OrpinSVPSell35,000$71.98$2,519,300.00View SEC Filing  
6/17/2013Nicholas NaclerioSVPSell2,000$68.56$137,120.00View SEC Filing  
6/14/2013Christian O HenrySVPSell25,959$68.10$1,767,807.90View SEC Filing  
6/13/2013Jay T FlatleyCEOSell20,000$66.49$1,329,800.00View SEC Filing  
6/13/2013Tristan OrpinSVPSell47,667$66.55$3,172,238.85View SEC Filing  
6/12/2013David R WaltDirectorSell5,000$67.67$338,350.00View SEC Filing  
6/12/2013Michel BouchardVPSell5,170$68.64$354,868.80View SEC Filing  
6/11/2013Mostafa RonaghiSVPSell24,000$69.01$1,656,240.00View SEC Filing  
6/3/2013Karin EasthamDirectorSell10,000$70.34$703,400.00View SEC Filing  
5/31/2013Mark L LewisSVPSell13,000$71.72$932,360.00View SEC Filing  
5/30/2013Matthew L PosardSVPSell2,836$70.80$200,788.80View SEC Filing  
5/29/2013David R WaltDirectorSell5,000$70.92$354,600.00View SEC Filing  
5/29/2013Michel BouchardVPSell6,276$71.02$445,721.52View SEC Filing  
5/21/2013Jay T FlatleyCEOSell24,000$69.39$1,665,360.00View SEC Filing  
5/20/2013Marc StapleyCFOSell2,843$73.38$208,619.34View SEC Filing  
5/15/2013David R WaltDirectorSell5,000$70.73$353,650.00View SEC Filing  
5/15/2013Michel BouchardVPSell14,241$70.71$1,006,981.11View SEC Filing  
5/15/2013Nicholas NaclerioSVPSell2,000$70.72$141,440.00View SEC Filing  
5/13/2013Mostafa RonaghiSVPSell24,000$68.83$1,651,920.00View SEC Filing  
5/10/2013Tristan OrpinSVPSell25,000$69.60$1,740,000.00View SEC Filing  
5/9/2013Jay T FlatleyCEOSell20,000$66.63$1,332,600.00View SEC Filing  
5/7/2013Tristan OrpinSVPSell5,000$65.68$328,400.00View SEC Filing  
4/8/2013Christian CabouSVPSell16,500$55.00$907,500.00View SEC Filing  
4/8/2013Marc StapleyCFOSell9,175$55.00$504,625.00View SEC Filing  
4/8/2013William H RastetterDirectorSell20,000$54.95$1,099,000.00View SEC Filing  
3/11/2013Marc StapleyCFOSell4,468$53.71$239,976.28View SEC Filing  
11/8/2012Jay T FlatleyCEOSell5,000$47.99$239,950.00View SEC Filing  
(Data available from 1/1/2013 forward)


Illumina (NASDAQ ILMN) News Headlines

Illumina (ILMN) Given Average Recommendation of "Buy" by BrokeragesIllumina (ILMN) Given Average Recommendation of "Buy" by Brokerages - March 18 at 3:27 PM
TMO’s Advanced Laboratory Management System Could Gain Market ShareTMO’s Advanced Laboratory Management System Could Gain Market Share - March 16 at 11:26 AM
Insider Selling: Illumina, Inc. (ILMN) Director Sells 250 Shares of StockInsider Selling: Illumina, Inc. (ILMN) Director Sells 250 Shares of Stock - March 15 at 10:26 PM
3 Things Investors Should Love About Illumina3 Things Investors Should Love About Illumina - March 14 at 11:19 AM
Illumina Banks on Product Launches & Strategic Partnerships - NasdaqIllumina Banks on Product Launches & Strategic Partnerships - Nasdaq - March 13 at 3:52 PM
Illumina Banks on Product Launches & Strategic PartnershipsIllumina Banks on Product Launches & Strategic Partnerships - March 13 at 11:04 AM
Illumina Names Dr. Phil Febbo Chief Medical OfficerIllumina Names Dr. Phil Febbo Chief Medical Officer - March 13 at 11:04 AM
Illumina (ILMN) Upgraded by BidaskClub to BuyIllumina (ILMN) Upgraded by BidaskClub to Buy - March 10 at 3:41 PM
Frances Arnold Sells 250 Shares of Illumina, Inc. (ILMN) StockFrances Arnold Sells 250 Shares of Illumina, Inc. (ILMN) Stock - March 8 at 9:50 PM
$742.73 Million in Sales Expected for Illumina, Inc. (ILMN) This Quarter$742.73 Million in Sales Expected for Illumina, Inc. (ILMN) This Quarter - March 7 at 9:36 AM
Illumina, Inc. (ILMN) SVP Charles Dadswell Sells 145 SharesIllumina, Inc. (ILMN) SVP Charles Dadswell Sells 145 Shares - March 6 at 9:58 PM
Illumina, Inc. (ILMN) Director Sells $458,740.00 in StockIllumina, Inc. (ILMN) Director Sells $458,740.00 in Stock - March 6 at 9:44 PM
Analyst Ratings for BioTelemetry and Its Peers in March 2018Analyst Ratings for BioTelemetry and Its Peers in March 2018 - March 6 at 3:42 PM
Understanding BioTelemetry’s Business StrategyUnderstanding BioTelemetry’s Business Strategy - March 6 at 3:42 PM
Illumina, Inc. (ILMN) EVP Omead Ostadan Sells 1,329 SharesIllumina, Inc. (ILMN) EVP Omead Ostadan Sells 1,329 Shares - March 5 at 9:30 PM
Illumina, Inc. (ILMN) Shares Bought by Moors & Cabot Inc.Illumina, Inc. (ILMN) Shares Bought by Moors & Cabot Inc. - March 5 at 4:18 PM
$1.02 EPS Expected for Illumina, Inc. (ILMN) This Quarter$1.02 EPS Expected for Illumina, Inc. (ILMN) This Quarter - March 5 at 1:18 PM
USA Financial Portformulas Corp Raises Holdings in Illumina, Inc. (ILMN)USA Financial Portformulas Corp Raises Holdings in Illumina, Inc. (ILMN) - March 4 at 2:47 PM
Geode Capital Management LLC Has $344.67 Million Holdings in Illumina, Inc. (ILMN)Geode Capital Management LLC Has $344.67 Million Holdings in Illumina, Inc. (ILMN) - March 4 at 1:48 PM
WINTON GROUP Ltd Lowers Holdings in Illumina, Inc. (ILMN)WINTON GROUP Ltd Lowers Holdings in Illumina, Inc. (ILMN) - March 3 at 2:58 PM
Standard Life Aberdeen plc Purchases 626 Shares of Illumina, Inc. (ILMN)Standard Life Aberdeen plc Purchases 626 Shares of Illumina, Inc. (ILMN) - March 3 at 11:50 AM
Illumina, Inc. (ILMN) Director Robert S. Epstein Sells 250 SharesIllumina, Inc. (ILMN) Director Robert S. Epstein Sells 250 Shares - March 2 at 9:32 PM
Eaton Vance Management Boosts Holdings in Illumina, Inc. (ILMN)Eaton Vance Management Boosts Holdings in Illumina, Inc. (ILMN) - March 2 at 11:53 AM
Illumina, Inc. (ILMN) Stake Boosted by Amalgamated BankIllumina, Inc. (ILMN) Stake Boosted by Amalgamated Bank - March 2 at 4:20 AM
Silicon Valley-based Illumina spinoff raising $200M for genetics ‘app store’Silicon Valley-based Illumina spinoff raising $200M for genetics ‘app store’ - March 1 at 10:27 AM
First Republic Investment Management Inc. Sells 536 Shares of Illumina, Inc. (ILMN)First Republic Investment Management Inc. Sells 536 Shares of Illumina, Inc. (ILMN) - March 1 at 9:12 AM
7,164 Shares in Illumina, Inc. (ILMN) Purchased by Ashfield Capital Partners LLC7,164 Shares in Illumina, Inc. (ILMN) Purchased by Ashfield Capital Partners LLC - March 1 at 4:42 AM
Illumina, Inc. (ILMN) Holdings Reduced by State of Tennessee Treasury DepartmentIllumina, Inc. (ILMN) Holdings Reduced by State of Tennessee Treasury Department - February 28 at 5:47 PM
15,600 Shares in Illumina, Inc. (ILMN) Purchased by Spark Investment Management LLC15,600 Shares in Illumina, Inc. (ILMN) Purchased by Spark Investment Management LLC - February 28 at 5:45 PM
Jackson Square Partners LLC Increases Stake in Illumina, Inc. (ILMN)Jackson Square Partners LLC Increases Stake in Illumina, Inc. (ILMN) - February 28 at 3:54 PM
Kingfisher Capital LLC Decreases Position in Illumina, Inc. (ILMN)Kingfisher Capital LLC Decreases Position in Illumina, Inc. (ILMN) - February 28 at 2:48 PM
Mérieux Développement and Paladin Capital Group Co-lead $55.5 Million Series C Financing Into Inscripta, a Leading Company in the Field of Gene Editing, in Preparation for Platform Expansion and Commercial LaunchMérieux Développement and Paladin Capital Group Co-lead $55.5 Million Series C Financing Into Inscripta, a Leading Company in the Field of Gene Editing, in Preparation for Platform Expansion and Commercial Launch - February 28 at 10:47 AM
Brown Advisory Inc. Raises Holdings in Illumina, Inc. (ILMN)Brown Advisory Inc. Raises Holdings in Illumina, Inc. (ILMN) - February 28 at 5:14 AM
Employees Retirement System of Texas Has $2.36 Million Holdings in Illumina, Inc. (ILMN)Employees Retirement System of Texas Has $2.36 Million Holdings in Illumina, Inc. (ILMN) - February 27 at 12:10 PM
Carillon Tower Advisers Inc. Takes Position in Illumina, Inc. (ILMN)Carillon Tower Advisers Inc. Takes Position in Illumina, Inc. (ILMN) - February 27 at 5:32 AM
MayTech Global Investments LLC Invests $3.39 Million in Illumina, Inc. (ILMN)MayTech Global Investments LLC Invests $3.39 Million in Illumina, Inc. (ILMN) - February 26 at 3:58 PM
First Week of ILMN April 20th Options Trading - NasdaqFirst Week of ILMN April 20th Options Trading - Nasdaq - February 26 at 3:40 PM
Biotech Stocks To Watch: Genomics Leader Eyes China FDA ApprovalBiotech Stocks To Watch: Genomics Leader Eyes China FDA Approval - February 26 at 3:40 PM
Winslow Capital Management LLC Has $229.56 Million Position in Illumina, Inc. (ILMN)Winslow Capital Management LLC Has $229.56 Million Position in Illumina, Inc. (ILMN) - February 26 at 1:10 PM
ARK Investment Management LLC Grows Position in Illumina, Inc. (ILMN)ARK Investment Management LLC Grows Position in Illumina, Inc. (ILMN) - February 26 at 5:12 AM
3 Top DNA Stocks to Consider Buying Now3 Top DNA Stocks to Consider Buying Now - February 23 at 3:43 PM
Q1 2019 EPS Estimates for Illumina, Inc. (ILMN) Decreased by William BlairQ1 2019 EPS Estimates for Illumina, Inc. (ILMN) Decreased by William Blair - February 22 at 2:08 PM
Illumina, Inc. (ILMN) Receives Average Recommendation of "Buy" from AnalystsIllumina, Inc. (ILMN) Receives Average Recommendation of "Buy" from Analysts - February 21 at 5:48 PM
Insider Selling: Illumina, Inc. (ILMN) SVP Sells 1,408 Shares of StockInsider Selling: Illumina, Inc. (ILMN) SVP Sells 1,408 Shares of Stock - February 21 at 12:14 AM
Microsoft Chairman John Thompson Talks Cloud Competition, Diversity, and New Rubrik Board SeatMicrosoft Chairman John Thompson Talks Cloud Competition, Diversity, and New Rubrik Board Seat - February 20 at 3:41 PM
Q3 2018 EPS Estimates for Illumina, Inc. (ILMN) Lowered by AnalystQ3 2018 EPS Estimates for Illumina, Inc. (ILMN) Lowered by Analyst - February 15 at 10:28 AM
Q4 2018 EPS Estimates for Illumina, Inc. Lifted by Analyst (ILMN)Q4 2018 EPS Estimates for Illumina, Inc. Lifted by Analyst (ILMN) - February 14 at 1:26 PM
Illumina Inc (ILMN) Files 10-K for the Fiscal Year Ended on December 31, 2017Illumina Inc (ILMN) Files 10-K for the Fiscal Year Ended on December 31, 2017 - February 13 at 3:18 PM
Analyzing Abaxis (ABAX) and Illumina (ILMN)Analyzing Abaxis (ABAX) and Illumina (ILMN) - February 9 at 9:10 PM
Marc Stapley Sells 2,000 Shares of Illumina, Inc. (ILMN) StockMarc Stapley Sells 2,000 Shares of Illumina, Inc. (ILMN) Stock - February 9 at 12:12 AM

SEC Filings

Illumina (NASDAQ:ILMN) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media


Illumina (NASDAQ:ILMN) Income Statement, Balance Sheet and Cash Flow Statement


Illumina (NASDAQ ILMN) Stock Chart for Monday, March, 19, 2018

Loading chart…

This page was last updated on 3/19/2018 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.